Date: Thursday, February 17th, 2022
In this webinar, the CPS COVID Task Force reviewed insights and best practices pertaining to new developments in pharmacy related to the continuing COVID-19 pandemic. Topics covered include virus variants, vaccine types, the therapeutic landscape, monoclonal antibodies, and more.
Topic: Updates and Insights from the COVID Task Force (22.02)
CPS provides resources, tools, and expertise to position pharmacies at our managed sites favorably to navigate the evolving circumstances of the COVID-19 pandemic. During this webinar, the CPS COVID Task Force led a discussion reviewing insights and updates for hospitals and health systems seeking to "connect the dots" as they navigate their pharmacies through the pandemic.
Topics included:
• COVID-19 and variants
• Vaccines
• mAbs
• Antivirals (orals and changes to remdesivir)
• Logistic, legal, ethical, and billing/reimbursement considerations
• COVID Task Force value delivery at our manged sites
Presenters:
Chris Beebe
RPH, MBA
Compliance and Regulatory Services
Rabiah Dys
PharmD
Clinical Program Development
Chuck Fogle
PharmD
Clinical Solutions
Davey Legendre
PharmD, MBA, BCPS-AQID
Clinical Infectious Diseases
Valerie Sheehan
PharmD
Clinical Program Development
Renee Zawistowski
PharmD, BCCP
Quality and Operations